0
Merus has reached its limit for free report views
Work for Merus? Upgrade Your Profile and unlock all your annual reports.
Merus
- 51-200 Employees
- Based in Utrecht, Netherlands
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Their most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
Merus
Most Recent Annual Report
Report Locked. Merus has reached its limit for free report views.
